Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
3.160
+0.040 (1.28%)
At close: Oct 15, 2025, 4:00 PM EDT
3.120
-0.040 (-1.27%)
After-hours: Oct 15, 2025, 7:47 PM EDT
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $18.63 million as of October 15, 2025. Its market cap has increased by 562.10% in one year.
Market Cap
18.63M
Enterprise Value
16.73M
1-Year Change
562.10%
Ranking
Category
Stock Price
$3.16
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has decreased from $41.18M to $18.63M, a decrease of -54.75%. That is a compound annual growth rate of -19.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 18.40M | 368.69% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
| Jan 12, 2022 | 41.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.63B |
| Johnson & Johnson | 453.06B |
| AbbVie | 404.56B |
| UnitedHealth Group | 326.95B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 229.31B |